Detalhe da pesquisa
1.
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
N Engl J Med
; 366(26): 2443-54, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22658127
2.
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab.
J Clin Oncol
; 41(5): 943-954, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750016
3.
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
JAMA Dermatol
; 159(5): 545-553, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920356
4.
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
JAMA Dermatol
; 156(9): 1004-1011, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32725204
5.
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.
JAMA Oncol
; 5(10): 1411-1420, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31343665
6.
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.
Melanoma Manag
; 4(1): 13-37, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758010
7.
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.
J Clin Oncol
; 32(10): 1020-30, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24590637
8.
A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).
Clin Cancer Res
; 19(15): 4228-38, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23653149